Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 252

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?

Open access
Colbeck, Emily Jayne, Ager, Ann, Gallimore, Awen, Jones, Gareth Wyn · 2017 · Frontiers in Immunology

Abstract

Secondary lymphoid organs are integral to initiation and execution of adaptive immune responses. These organs provide a setting for interactions between antigen-specific lymphocytes and antigen-presenting cells recruited from local infected or inflamed tissues. Secondary lymphoid organs develop as part of a genetically pre-programmed process during embryogenesis. However, organogenesis of secondary lymphoid tissues can also be recapitulated in adulthood during de novo lymphoid neogenesis of tertiary lymphoid structures (TLS). These ectopic lymphoid-like structures form in inflamed tissues afflicted by various pathological conditions, including cancer, autoimmunity, infection or allograft rejection. Studies are beginning to shed light on the function of such structures in different disease settings raising important questions regarding their contribution to progression or resolution of disease. Data show an association between tumor-associated TLS and a favorable prognosis in various types of human cancer, attracting the speculation that TLS support effective local anti-tumor immune responses. However, definitive evidence for a role for TLS in fostering immune responses in vivo are lacking, with current data remaining largely correlative by nature. In fact, some more recent studies have even demonstrated an immunosuppressive, tumor-promoting role for cancer associated TLS. In this review, we will discuss what is known about the development of cancer-associated TLS and the current understanding of their potential role in the anti-tumor immune response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2017.01830

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 252

Metadata

Authors
Colbeck, E. J., Ager, A., Gallimore, A., & Jones, G. W.
Venue
Frontiers in Immunology
Published
2017-12-19
Volume
8
Pages
1830-1830
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2776272710
Cited by
252
References
7
FWCI
6.79
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease? https://app.cochat.ai/papers/10.3389/fimmu.2017.01830
The paper
Colbeck, E. J., Ager, A., Gallimore, A., & Jones, G. W. (2017). Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease? Frontiers in Immunology. https://doi.org/10.3389/fimmu.2017.01830

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.